Could China’s New GLP-1 Drugs Beat Out Ozempic? GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes By Rachel Fieldhouse & Nature magazine A drug that outperforms placebo in helping people to lose weight is one of a growing number of…